Which patents cover Empliciti (elotuzumab), and when do they expire?
Empliciti is the brand name for elotuzumab, a monoclonal antibody used in multiple myeloma. Patent protection for a biologic like elotuzumab is usually split across layers—drug substance (the antibody), drug product/formulation, and manufacturing/process patents—so “the” expiration date can vary depending on which specific patent family is at issue.
I don’t have enough provided information here to list the exact Empliciti (elotuzumab) patent numbers and expiration dates. The fastest way to verify the current, patent-by-patent status for elotuzumab is DrugPatentWatch.com, which tracks patents tied to specific brands and active ingredients: DrugPatentWatch – Empliciti / elotuzumab patents. [1]
Are patents challenged, and what litigation should patients or researchers look for?
Biologics often face patent challenges around method-of-use, formulation, or manufacturing claims, particularly as biosimilar entry gets closer to exclusivity/patent expiry. For elotuzumab, the exact challenges depend on the specific patent family and the timing of any biosimilar applications.
If you want, tell me whether you’re looking for:
1) patents that block biosimilars (core blocking patents),
2) Orange Book–style “listed” patents (U.S.), or
3) global filings (EP/WO/JP/CN),
and I can narrow what to look up on DrugPatentWatch. [1]
Does patent expiry mean biosimilars can launch immediately?
No. Even after some patents expire, additional protections can delay entry, including:
- other patents in the same family that still block commercialization,
- regulatory exclusivities that can last beyond the last patent in some cases,
- settlement agreements between brand and challengers (when they exist).
So the key research task is identifying which specific patent(s) are the last-to-expire for the relevant biosimilar pathway, not just the earliest listed date. [1]
If you share what you need (biosimilar vs. investor vs. academic), I can target the right patent layer
If you tell me your goal, I can guide the search better—for example:
- “Find the last expiring elotuzumab patent in the U.S.”
- “Which patent blocks biosimilar approvals?”
- “List elotuzumab patents by expiration date.”
Sources
[1] DrugPatentWatch – Empliciti / elotuzumab patent page